This public procurement record has 2 releases in its history.

TenderUpdate

22 Jul 2024 at 10:07

Award

09 Jul 2024 at 14:32

Summary of the contracting process

NHS Suffolk and North East Essex ICB has recently concluded the award stage of their "SNEE Covid-19 Oral Antiviral Treatment Service" contract. This procurement falls within the health services category, specifically targeting Covid-19 oral antiviral treatments for non-hospitalised patients in Suffolk and North East Essex. The procurement method used was a direct award under the Health Care Services (Provider Selection Regime) Regulations 2023, with the contract formally awarded on 27th June 2024. The service period extends from 27th June 2024 to 31st March 2025, and the contract’s total value excluding VAT is anticipated to be £8,550.00. Additionally, significant providers including Boots, Belstead Hills Pharmacy, and several others were selected to participate in delivering this service.

This tender offers a substantial opportunity for both large and small healthcare businesses, particularly those specialising in pharmaceutical services and community healthcare delivery. Businesses with a robust capacity to maintain stock levels and ensure rapid distribution of antiviral medications are well-suited for this contract. The service requirements emphasize prompt access and efficient management, making it ideal for pharmacies and healthcare providers that can swiftly adapt to local demands and ensure seamless integration with the SNEE Covid Management Delivery Unit (CMDU). Providers involved will benefit from a structured demand for antiviral treatments, which can support business growth and service expansion within the healthcare sector.

How relevant is this notice?

Notice Title

SNEE Covid-19 Oral Antiviral Treatment Service

Notice Description

The aim of this service is to provide the clinical infrastructure to support the safe, timely and appropriate dispensing of antiviral medication for the treatment of Covid-19 for non-hospitalised patients across Suffolk and North East Essex. The service is designed to ensure choice and prompt access to these medicines in the community setting for eligible patients when they are required at all times whilst the pharmacies are open. Each provider will stock a minimum of THREE packs of each antiviral medication (or higher based on local demand) and will make a commitment to ensure eligible patients have prompt access to these medicines to facilitate treatment within 5 days of the onset of symptoms. Patients will receive a full clinical review by a SNEE Covid Management Delivery Unit (CMDU) prescriber and if eligible for treatment, an EPS prescription will be sent to the commissioned community pharmacy, in line with the consent and choice of the patient. Pharmacists will contact the patient as soon as possible upon receipt of the prescription to confirm consent and clinical suitability for treatment. This discussion is recorded on an electronic platform confirming all checks have been performed to confirm appropriateness of treatment. As appropriate, the pharmacy will make arrangement with the patient/carer for the medication to be collected or delivered.

Lot Information

Lot 1

The aim of this service is to provide the clinical infrastructure to support the safe, timely and appropriate dispensing of antiviral medication for the treatment of Covid-19 for non-hospitalised patients across Suffolk and North East Essex. The service is designed to ensure choice and prompt access to these medicines in the community setting for eligible patients when they are required at all times whilst the pharmacies are open. Each provider will stock a minimum of THREE packs of each antiviral medication (or higher based on local demand) and will make a commitment to ensure eligible patients have prompt access to these medicines to facilitate treatment within 5 days of the onset of symptoms. Commissioned pharmacies will be required to report stockholding to the ICB on a monthly basis for ongoing assurance. Patients will receive a full clinical review by a SNEE Covid Management Delivery Unit (CMDU) prescriber and if eligible for treatment, an EPS prescription will be sent to the commissioned community pharmacy, in line with the consent and choice of the patient. Pharmacists will contact the patient as soon as possible upon receipt of the prescription to confirm consent and clinical suitability for treatment. This discussion is recorded on an electronic platform confirming all relevant clinical and pharmaceutical compatibility checks have been performed to confirm appropriateness of treatment. If necessary, the community pharmacist will contact the prescriber to clarify clinical concerns and/or in the event of stock availability issues. Otherwise, as appropriate, the pharmacy will make arrangement with the patient/carer for the medication to be collected or delivered. Deliveries of medication are expected to be in exceptional circumstances but can be arranged and remunerated under this service. The current contract period was 27-06-2023 to 26-06-2024 with no option to extend. This is an extension for 9 months of that original contract. NHS Suffolk and North East Essex Integrated Care Board are awarding the contract named within this notice under the Direct Award C process which is outlined within the Health Care Services (Provider Selection Regime) Regulations 2023. The provider named in this notice is an existing provider and has been reviewed through a Key Criteria assessment to ensure the awarding body is satisfied with current performance and reasonably expects the provider to be able to satisfy the contract which is the subject of this notice. The contract which is the subject of this notice has not changed considerably when compared with the existing / previous contract delivered by the named provider. The ICB may wish to introduce additional services during the lifetime of the contract ("Contract modifications"). Such contract modifications will be contemplated where additional requirements are similar and or complementary to the services already included in the Specification, at any given time. Such expansion would be by the addition of services commissioned by the Authority as named in the Contract Notice. To this end, after the award of contract, there is a possibility that the contract may be varied as allowable in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023. Additional information: The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.

Procurement Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 19th July 2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-047bf0
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/022615-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£475 Under £100K

Notice Dates

Publication Date
22 Jul 20242 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
27 Jun 20242 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS Suffolk and North East Essex ICB
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
COLCHESTER
Postcode
CO4 9QR
Postcode Area
Colchester
Country
England

Major Region (ITL 1)
TLH East (England)
Basic Region (ITL 2)
TLH3 Essex
Small Region (ITL 3)
TLH34 Essex Haven Gateway
Delivery Location
TLH14 Suffolk CC, TLH34 Essex Haven Gateway

Local Authority
Colchester
Electoral Ward
Highwoods
Westminster Constituency
Colchester

Supplier Information

Number of Suppliers
16
Supplier Names

Belstead Hills Pharmacy

Boots

Cavalry Road Pharmacy

Framlingham Pharmacy

Guildhall Pharmacy

Holland Pharmacy

Island Pharmacy

Long Melford Pharmacy

Lords Pharmacy

Manor Court Pharmacy

Martlesham Pharmacy

Queen Street Pharmacy

Walton Pharmacy

Wickham Market Pharmacy

Woodbridge Road Pharmacy

Woolpit Health Centre

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...